New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 20.6 g/l (per litre of amino acid solution);  ; arginine 13.95 g/l (per litre of amino acid solution); aspartic acid 4.12 g/l (per litre of amino acid solution);  ; glutamic acid 7.11 g/l (per litre of amino acid solution); glycine 9.87 g/l (per litre of amino acid solution);  ; histidine 8.49 g/l (per litre of amino acid solution); isoleucine 7.11 g/l (per litre of amino acid solution);  ; leucine 9.87 g/l (per litre of amino acid solution);  ;  ; lysine acetate 15.8 g/l equivalent to lysine 11.2 g/l;  ; methionine 7.11 g/l (per litre of amino acid solution);  ; phenylalanine 9.87 g/l (per litre of amino acid solution);  ; proline 8.49 g/l (per litre of amino acid solution); serine 5.62 g/l (per litre of amino acid solution); threonine 7.11 g/l (per litre of amino acid solution);  ;  ; tryptophan 2.37 g/l (per litre of amino acid solution);  ; tyrosine 0.37 g/l (per litre of amino acid solution);  ; valine 9.11 g/l (per litre of amino acid solution);  ;  ; glucose monohydrate 302.5 g/l equivalent to glucose 275 g/l;  ;  ; olive oil 160 g/l (per litre of lipid emulsion); soya oil 40 g/l (per litre of lipid emulsion);   - emulsion for infusion - active: alanine 20.6 g/l (per litre of amino acid solution)   arginine 13.95 g/l (per litre of amino acid solution) aspartic acid 4.12 g/l (per litre of amino acid solution)   glutamic acid 7.11 g/l (per litre of amino acid solution) glycine 9.87 g/l (per litre of amino acid solution)   histidine 8.49 g/l (per litre of amino acid solution) isoleucine 7.11 g/l (per litre of amino acid solution)   leucine 9.87 g/l (per litre of amino acid solution)     lysine acetate 15.8 g/l equivalent to lysine 11.2 g/l   methionine 7.11 g/l (per litre of amino acid solution)   phenylalanine 9.87 g/l (per litre of amino acid solution)   proline 8.49 g/l (per litre of amino acid solution) serine 5.62 g/l (per litre of amino acid solution) threonine 7.11 g/l (per litre of amino acid solution)     tryptophan 2.37 g/l (per litre of amino acid solution)   tyrosine 0.37 g/l (per litre of amino acid solution)   valine 9.11 g/l (per litre of amino acid solution)     excipient: glacial acetic acid nitrogen water for injection active: glucose monohydrate 302.5 g/l equivalent to glucose 275 g/l     excipient: hydrochloric acid water for injection active: olive oil 160 g/l (per litre of lipid emulsion) soya oil 40 g/l (per litre of lipid emulsion)   excipient: egg phosphatidyl esters glycerol sodium hydroxide sodium oleate water for injection - parenteral nutrition for adults when oral or enteral nutrition is not possible, insufficient, or contraindicated.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 20.6 g/l (per litre of amino acid solution);  ; arginine 13.95 g/l (per litre of amino acid solution); aspartic acid 4.12 g/l (per litre of amino acid solution);  ; glutamic acid 7.11 g/l (per litre of amino acid solution); glycine 9.87 g/l (per litre of amino acid solution);  ; histidine 8.49 g/l (per litre of amino acid solution); isoleucine 7.11 g/l (per litre of amino acid solution);  ; leucine 9.87 g/l (per litre of amino acid solution);  ;  ; lysine acetate 15.8 g/l equivalent to lysine 11.2 g/l;  ; magnesium chloride hexahydrate 2.03 g/l (per litre of amino acid solution);  ; methionine 7.11 g/l (per litre of amino acid solution);  ; phenylalanine 9.87 g/l (per litre of amino acid solution);  ; potassium chloride 5.59 g/l (per litre of amino acid solution);  ;  ; proline 8.49 g/l (per litre of amino acid solution); serine 5.62 g/l (per litre of amino acid solution); sodium acetate trihydrate 3.74 g/l (per litre of amino acid solution);  ; sodium glycerophosphate 9.18 g/l (per litre of amino acid solution (hydrated)); threonine 7.11 g/l (per litre of amino acid solution); tryptophan 2.37 g/l (per litre of amino acid solution); tyrosine 0.37 g/l (per litre of amino acid solution);  ; valine 9.11 g/l (per litre of amino acid solution); calcium chloride dihydrate 1.29 g/l (per litre glucose solution);  ; glucose monohydrate 302.5 g/l equivalent to glucose 275 g/l;  ;  ; olive oil 160 g/l (per litre of lipid emulsion); soya oil 40 g/l (per litre of lipid emulsion);   - emulsion for infusion - active: alanine 20.6 g/l (per litre of amino acid solution)   arginine 13.95 g/l (per litre of amino acid solution) aspartic acid 4.12 g/l (per litre of amino acid solution)   glutamic acid 7.11 g/l (per litre of amino acid solution) glycine 9.87 g/l (per litre of amino acid solution)   histidine 8.49 g/l (per litre of amino acid solution) isoleucine 7.11 g/l (per litre of amino acid solution)   leucine 9.87 g/l (per litre of amino acid solution)     lysine acetate 15.8 g/l equivalent to lysine 11.2 g/l   magnesium chloride hexahydrate 2.03 g/l (per litre of amino acid solution)   methionine 7.11 g/l (per litre of amino acid solution)   phenylalanine 9.87 g/l (per litre of amino acid solution)   potassium chloride 5.59 g/l (per litre of amino acid solution)     proline 8.49 g/l (per litre of amino acid solution) serine 5.62 g/l (per litre of amino acid solution) sodium acetate trihydrate 3.74 g/l (per litre of amino acid solution)   sodium glycerophosphate 9.18 g/l (per litre of amino acid solution (hydrated)) threonine 7.11 g/l (per litre of amino acid solution) tryptophan 2.37 g/l (per litre of amino acid solution) tyrosine 0.37 g/l (per litre of amino acid solution)   valine 9.11 g/l (per litre of amino acid solution) excipient: glacial acetic acid water for injection active: calcium chloride dihydrate 1.29 g/l (per litre glucose solution)   glucose monohydrate 302.5 g/l equivalent to glucose 275 g/l     excipient: hydrochloric acid water for injection active: olive oil 160 g/l (per litre of lipid emulsion) soya oil 40 g/l (per litre of lipid emulsion)   excipient: egg phosphatidyl esters glycerol sodium hydroxide sodium oleate water for injection - parenteral nutrition for adults when oral or enteral nutrition is not possible, insufficient, or contraindicated.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 9.16 g/l (per litre of amino acid solution);  ; arginine 6.2 g/l (per litre of amino acid solution); aspartic acid 1.83 g/l (per litre of amino acid solution);  ; glutamic acid 3.16 g/l (per litre of amino acid solution); glycine 4.39 g/l (per litre of amino acid solution);  ; histidine 3.77 g/l (per litre of amino acid solution); isoleucine 3.16 g/l (per litre of amino acid solution);  ; leucine 4.39 g/l (per litre of amino acid solution);  ;  ; lysine acetate 7.02 g/l equivalent to lysine 4.98 g/l;  ; magnesium chloride hexahydrate 1.12 g/l (per litre of amino acid solution);  ; methionine 3.16 g/l (per litre of amino acid solution);  ; phenylalanine 4.39 g/l (per litre of amino acid solution);  ; potassium chloride 2.98 g/l (per litre of amino acid solution);  ;  ; proline 3.77 g/l (per litre of amino acid solution); serine 2.5 g/l (per litre of amino acid solution); sodium acetate trihydrate 2.89 g/l (per litre of amino acid solution);  ; sodium glycerophosphate 4.78 g/l (per litre of amino acid solution (hydrated)); threonine 3.16 g/l (per litre of amino acid solution); tryptophan 1.06 g/l (per litre of amino acid solution); tyrosine 0.16 g/l (per litre of amino acid solution);  ; valine 4.05 g/l (per litre of amino acid solution);  ; calcium chloride dihydrate 0.74 g/l (per litre glucose solution);  ; glucose monohydrate 206.25 g/l equivalent to glucose 187.5 g/l;  ;  ; olive oil 120 g/l (per litre lipid emulsion); soya oil 30 g/l (per litre lipid emulsion);   - emulsion for infusion - active: alanine 9.16 g/l (per litre of amino acid solution)   arginine 6.2 g/l (per litre of amino acid solution) aspartic acid 1.83 g/l (per litre of amino acid solution)   glutamic acid 3.16 g/l (per litre of amino acid solution) glycine 4.39 g/l (per litre of amino acid solution)   histidine 3.77 g/l (per litre of amino acid solution) isoleucine 3.16 g/l (per litre of amino acid solution)   leucine 4.39 g/l (per litre of amino acid solution)     lysine acetate 7.02 g/l equivalent to lysine 4.98 g/l   magnesium chloride hexahydrate 1.12 g/l (per litre of amino acid solution)   methionine 3.16 g/l (per litre of amino acid solution)   phenylalanine 4.39 g/l (per litre of amino acid solution)   potassium chloride 2.98 g/l (per litre of amino acid solution)     proline 3.77 g/l (per litre of amino acid solution) serine 2.5 g/l (per litre of amino acid solution) sodium acetate trihydrate 2.89 g/l (per litre of amino acid solution)   sodium glycerophosphate 4.78 g/l (per litre of amino acid solution (hydrated)) threonine 3.16 g/l (per litre of amino acid solution) tryptophan 1.06 g/l (per litre of amino acid solution) tyrosine 0.16 g/l (per litre of amino acid solution)   valine 4.05 g/l (per litre of amino acid solution)   excipient: glacial acetic acid water for injection active: calcium chloride dihydrate 0.74 g/l (per litre glucose solution)   glucose monohydrate 206.25 g/l equivalent to glucose 187.5 g/l     excipient: hydrochloric acid water for injection active: olive oil 120 g/l (per litre lipid emulsion) soya oil 30 g/l (per litre lipid emulsion)   excipient: egg phosphatidyl esters glycerol sodium hydroxide sodium oleate water for injection - parenteral nutrition for adults when oral or enteral nutrition is not possible, insufficient, or contraindicated.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 8 g/l;  ;  ;  ; arginine 8.4 g/l;  ;  ;  ; aspartic acid 6 g/l;  ;  ; cysteine 1.89 g/l;  ; glutamic acid 10 g/l;  ; glycine 4 g/l;  ;  ; histidine 3.8 g/l;  ;  ; isoleucine 6.7 g/l;  ;  ;  ;  ;  ; leucine 10 g/l;  ;  ;  ;  ; lysine 11 g/l; methionine 2.4 g/l;  ;  ; ornithine hydrochloride 3.18 g/l;  ; phenylalanine 4.2 g/l;  ;  ;  ;  ; proline 3 g/l;  ;  ; serine 4 g/l;  ;  ; taurine 0.6 g/l;  ; threonine 3.7 g/l;  ;  ;  ; tryptophan 2 g/l;  ;  ;  ; tyrosine 0.45 g/l;  ;  ; valine 7.6 g/l;  ;   - solution for infusion - 10 % - active: alanine 8 g/l       arginine 8.4 g/l       aspartic acid 6 g/l     cysteine 1.89 g/l   glutamic acid 10 g/l   glycine 4 g/l     histidine 3.8 g/l     isoleucine 6.7 g/l           leucine 10 g/l         lysine 11 g/l methionine 2.4 g/l     ornithine hydrochloride 3.18 g/l   phenylalanine 4.2 g/l         proline 3 g/l     serine 4 g/l     taurine 0.6 g/l   threonine 3.7 g/l       tryptophan 2 g/l       tyrosine 0.45 g/l     valine 7.6 g/l     excipient: malic acid water for injection - primene 10% amino acids iv infusion solution is indicated in infants and neonates at term or premature for short-term use, of normal or low birth-weight when oral or enteral nutrition is impossible, insufficient or contraindicated. it is used as an amino acid component in a composite admixture of total parenteral solution.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 16.5 g/l;  ; arginine 9.19 g/l;  ; glycine 8.23 g/l;  ; histidine 3.84 g/l;  ; isoleucine 4.79 g/l;  ; leucine 5.83 g/l;  ; lysine 4.63 g/l;  ; methionine 3.2 g/l;  ; phenylalanine 4.47 g/l;  ; proline 5.43 g/l;  ; serine 4 g/l; threonine 3.36 g/l;  ; tryptophan 1.44 g/l;  ; tyrosine 0.32 g/l;  ; valine 4.63 g/l;   - solution for infusion - 8 % - active: alanine 16.5 g/l   arginine 9.19 g/l   glycine 8.23 g/l   histidine 3.84 g/l   isoleucine 4.79 g/l   leucine 5.83 g/l   lysine 4.63 g/l   methionine 3.2 g/l   phenylalanine 4.47 g/l   proline 5.43 g/l   serine 4 g/l threonine 3.36 g/l   tryptophan 1.44 g/l   tyrosine 0.32 g/l   valine 4.63 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 16.5 g/l;  ; arginine 9.19 g/l;  ; dibasic potassium phosphate 5.22 g/l; glycine 8.23 g/l;  ; histidine 3.84 g/l;  ; isoleucine 4.79 g/l;  ; leucine 5.83 g/l;  ; lysine 4.63 g/l;  ; magnesium chloride hexahydrate 1.02 g/l; methionine 3.2 g/l;  ; phenylalanine 4.47 g/l;  ; proline 5.43 g/l;  ; serine 4 g/l; sodium acetate trihydrate 6.8 g/l; sodium chloride 1.17 g/l; threonine 3.36 g/l;  ; tryptophan 1.44 g/l;  ; tyrosine 0.32 g/l;  ; valine 4.63 g/l;   - solution for infusion - 8 % - active: alanine 16.5 g/l   arginine 9.19 g/l   dibasic potassium phosphate 5.22 g/l glycine 8.23 g/l   histidine 3.84 g/l   isoleucine 4.79 g/l   leucine 5.83 g/l   lysine 4.63 g/l   magnesium chloride hexahydrate 1.02 g/l methionine 3.2 g/l   phenylalanine 4.47 g/l   proline 5.43 g/l   serine 4 g/l sodium acetate trihydrate 6.8 g/l sodium chloride 1.17 g/l threonine 3.36 g/l   tryptophan 1.44 g/l   tyrosine 0.32 g/l   valine 4.63 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 20.7 g/l;  ; arginine 11.5 g/l;  ; glycine 10.3 g/l;  ; histidine 4.8 g/l;  ; isoleucine 6 g/l;  ; leucine 7.3 g/l;  ; lysine 5.8 g/l;  ; methionine 4 g/l;  ; phenylalanine 5.6 g/l;  ; proline 6.8 g/l;  ; serine 5 g/l; threonine 4.2 g/l;  ; tryptophan 1.8 g/l;  ; tyrosine 0.4 g/l;  ; valine 5.8 g/l;   - solution for infusion - 10 % - active: alanine 20.7 g/l   arginine 11.5 g/l   glycine 10.3 g/l   histidine 4.8 g/l   isoleucine 6 g/l   leucine 7.3 g/l   lysine 5.8 g/l   methionine 4 g/l   phenylalanine 5.6 g/l   proline 6.8 g/l   serine 5 g/l threonine 4.2 g/l   tryptophan 1.8 g/l   tyrosine 0.4 g/l   valine 5.8 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 20.7 g/l;  ; arginine 11.5 g/l;  ; dibasic potassium phosphate 5.22 g/l; glycine 10.3 g/l;  ; histidine 4.8 g/l;  ; isoleucine 6 g/l;  ; leucine 7.3 g/l;  ; lysine 5.8 g/l;  ; magnesium chloride hexahydrate 1.02 g/l; methionine 4 g/l;  ; phenylalanine 5.6 g/l;  ; proline 6.8 g/l;  ; serine 5 g/l; sodium acetate trihydrate 6.8 g/l; sodium chloride 1.17 g/l; threonine 4.2 g/l;  ; tryptophan 1.8 g/l;  ; tyrosine 0.4 g/l;  ; valine 5.8 g/l;   - solution for infusion - 10 % - active: alanine 20.7 g/l   arginine 11.5 g/l   dibasic potassium phosphate 5.22 g/l glycine 10.3 g/l   histidine 4.8 g/l   isoleucine 6 g/l   leucine 7.3 g/l   lysine 5.8 g/l   magnesium chloride hexahydrate 1.02 g/l methionine 4 g/l   phenylalanine 5.6 g/l   proline 6.8 g/l   serine 5 g/l sodium acetate trihydrate 6.8 g/l sodium chloride 1.17 g/l threonine 4.2 g/l   tryptophan 1.8 g/l   tyrosine 0.4 g/l   valine 5.8 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 11.4 g/l;  ; arginine 6.32 g/l;  ; glycine 5.66 g/l;  ; histidine 2.64 g/l;  ; isoleucine 3.3 g/l;  ; leucine 4.02 g/l;  ; lysine 3.19 g/l;  ; methionine 2.2 g/l;  ; phenylalanine 3.08 g/l;  ; proline 3.74 g/l;  ; serine 2.75 g/l; threonine 2.31 g/l;  ; tryptophan 0.99 g/l;  ; tyrosine 0.22 g/l;  ; valine 3.19 g/l;   - solution for infusion - 5.5 % - active: alanine 11.4 g/l   arginine 6.32 g/l   glycine 5.66 g/l   histidine 2.64 g/l   isoleucine 3.3 g/l   leucine 4.02 g/l   lysine 3.19 g/l   methionine 2.2 g/l   phenylalanine 3.08 g/l   proline 3.74 g/l   serine 2.75 g/l threonine 2.31 g/l   tryptophan 0.99 g/l   tyrosine 0.22 g/l   valine 3.19 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 11.4 g/l;  ; arginine 6.32 g/l;  ; dibasic potassium phosphate 5.22 g/l; glycine 5.66 g/l;  ; histidine 2.64 g/l;  ; isoleucine 3.3 g/l;  ; leucine 4.02 g/l;  ; lysine 3.19 g/l;  ; magnesium chloride hexahydrate 1.02 g/l; methionine 2.2 g/l;  ; phenylalanine 3.08 g/l;  ; proline 3.74 g/l;  ; serine 2.75 g/l; sodium acetate trihydrate 4.31 g/l; sodium chloride 2.24 g/l; threonine 2.31 g/l;  ; tryptophan 0.99 g/l;  ; tyrosine 0.22 g/l;  ; valine 3.19 g/l;   - solution for infusion - 5.5 % - active: alanine 11.4 g/l   arginine 6.32 g/l   dibasic potassium phosphate 5.22 g/l glycine 5.66 g/l   histidine 2.64 g/l   isoleucine 3.3 g/l   leucine 4.02 g/l   lysine 3.19 g/l   magnesium chloride hexahydrate 1.02 g/l methionine 2.2 g/l   phenylalanine 3.08 g/l   proline 3.74 g/l   serine 2.75 g/l sodium acetate trihydrate 4.31 g/l sodium chloride 2.24 g/l threonine 2.31 g/l   tryptophan 0.99 g/l   tyrosine 0.22 g/l   valine 3.19 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.